Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Neuronal Excitability

Characterization of the Brain Functional Architecture of Psychostimulant Withdrawal Using Single-Cell Whole-Brain Imaging

Adam Kimbrough, Marsida Kallupi, Lauren C. Smith, Sierra Simpson, Andres Collazo and Olivier George
eNeuro 27 September 2021, 8 (6) ENEURO.0208-19.2021; DOI: https://doi.org/10.1523/ENEURO.0208-19.2021
Adam Kimbrough
1School of Medicine, Department of Psychiatry, University of California San Diego, La Jolla, CA 92093
2College of Veterinary Medicine, Department of Basic Medical Sciences, Purdue University, West Lafayette, IN 47907
3Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam Kimbrough
Marsida Kallupi
1School of Medicine, Department of Psychiatry, University of California San Diego, La Jolla, CA 92093
3Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren C. Smith
1School of Medicine, Department of Psychiatry, University of California San Diego, La Jolla, CA 92093
3Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sierra Simpson
1School of Medicine, Department of Psychiatry, University of California San Diego, La Jolla, CA 92093
3Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andres Collazo
4Beckman Institute, Cal-Tech, Pasadena, CA 91125
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier George
1School of Medicine, Department of Psychiatry, University of California San Diego, La Jolla, CA 92093
3Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier George
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Numerous brain regions have been identified as contributing to withdrawal behaviors, but it is unclear the way in which these brain regions as a whole lead to withdrawal. The search for a final common brain pathway that is involved in withdrawal remains elusive. To address this question, we implanted osmotic minipumps containing either saline, nicotine (24 mg/kg/d), cocaine (60 mg/kg/d), or methamphetamine (4 mg/kg/d) for one week in male C57BL/6J mice. After one week, the minipumps were removed and brains collected 8 h (saline, nicotine, and cocaine) or 12 h (methamphetamine) after removal. We then performed single-cell whole-brain imaging of neural activity during the withdrawal period when brains were collected. We used hierarchical clustering and graph theory to identify similarities and differences in brain functional architecture. Although methamphetamine and cocaine shared some network similarities, the main common neuroadaptation between these psychostimulant drugs was a dramatic decrease in modularity, with a shift from a cortical-driven to subcortical-driven network, including a decrease in total hub brain regions. These results demonstrate that psychostimulant withdrawal produces the drug-dependent remodeling of functional architecture of the brain and suggest that the decreased modularity of brain functional networks and not a specific set of brain regions may represent the final common pathway associated with withdrawal.

  • addiction
  • functional connectivity
  • graph theory
  • iDISCO
  • neural activity
  • withdrawal

Significance Statement

A key aspect of treating drug abuse is understanding similarities and differences of how drugs of abuse affect the brain. In the present study, we examined how the brain is altered during withdrawal from psychostimulants. We found that each drug produced a unique pattern of activity in the brain, but that brains in withdrawal from cocaine and methamphetamine shared similar features. Interestingly, we found the major common link between withdrawal from all psychostimulants, when compared with controls, was a shift in the broad organization of the brain in the form of reduced modularity. Reduced modularity has been shown in several brain disorders, including traumatic brain injury, and dementia, and may be the common link between drugs of abuse.

Introduction

Psychostimulants are a class of highly addictive and commonly abused drugs that includes cocaine, nicotine, and methamphetamine (Balfour, 2008; Phillips et al., 2014). A large number of brain regions have been implicated in withdrawal associated with psychostimulant use (Kalivas and McFarland, 2003; Robinson and Kolb, 2004; Kalivas, 2007; Everitt et al., 2008; Jedynak et al., 2012; Koob and Volkow, 2016; Bobadilla et al., 2017). However, the complete neural network that is associated with psychostimulant withdrawal remains understudied, and the search for a common brain pathway that is responsible for psychostimulant withdrawal remains elusive. Common features of withdrawal may not be found at the brain region level but rather at the network level.

The identification of changes in neural network structure that are caused by psychostimulant withdrawal may be critical to understanding the ways in which these drugs affect the brain. Previous studies identified changes in network function after psychostimulant use (Tomasi et al., 2010; Konova et al., 2013, 2015; Ma et al., 2015), but these analyses focused on macroscale changes and not the mesoscale level, or they focused on preselected regions of interest.

The present study sought to identify the ways in which withdrawal from different commonly abused psychostimulants alters functional architecture of the brain. We hypothesized that withdrawal from psychostimulants would result in changes in functional neural networks and decrease modular structuring of the brain. We further hypothesized that each psychostimulant that was examined herein (i.e., methamphetamine, nicotine, and cocaine) would have a unique neural network that is associated with withdrawal. We measured single-cell whole-brain activity using Fos as a marker for neuronal activation in mice that underwent withdrawal from chronic psychostimulant (cocaine, methamphetamine, and nicotine) administration. To accomplish this, mice were implanted with osmotic minipumps for one week to induce dependence to each drug. Following one-week minipumps were removed and brains were collected from mice during acute withdrawal. This method of acute withdrawal was chosen to control the amount of drug each animal received and create strong dependence in a short period of time. The psychostimulant doses were chosen based on previous studies that reported rewarding effects during use and observed withdrawal-like symptoms after the cessation of chronic exposure for each drug (Johnson et al., 2008; Fish et al., 2010; Eisener-Dorman et al., 2011; Stoker and Markou, 2011; Stoker et al., 2012; Tracy et al., 2016; Zhu et al., 2017). We then used single-cell whole-brain activity to identify coactivation patterns of brain regions in the network that was associated with each treatment using hierarchical clustering. The functional connectivity measures were used to determine the modular structuring of each network. Graph theory was then used to further characterize each network to determine the brain regions that are most heavily involved in intramodular and intermodular connectivity of the functional network.

Materials and Methods

Animals

Male C57BL/6J mice were bred at The Scripps Research Institute. They were 20–30 g and 60 d old at the start of the experiment. The mice were maintained on a 12/12 h light/dark cycle with ad libitum access to food and water. All of the procedures were conducted in strict adherence to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by The Scripps Research Institute Institutional Animal Care and Use Committee and by the Institutional Animal Care and Use Committee of the University of California.

Drugs

The doses were 4 mg/kg/d for methamphetamine, 24 mg/kg/d for nicotine, and 60 mg/kg/d for cocaine. These doses were chosen based on previous studies that indicated rewarding effects during use, resulting in withdrawal-like symptoms after the cessation of chronic use (Johnson et al., 2008; Fish et al., 2010; Eisener-Dorman et al., 2011; Stoker and Markou, 2011; Stoker et al., 2012; Tracy et al., 2016; Zhu et al., 2017). Each drug was dissolved in saline, and the pH was adjusted to 7.4. The drugs were loaded into osmotic minipumps (Alzet; model 1002). The minipumps sat overnight in saline before insertion to ensure that drug delivery would begin immediately.

Minipump implantation and removal

The mice were split into four groups for the experiment: methamphetamine withdrawal group (n = 5), nicotine withdrawal group (n = 5), cocaine withdrawal group (n = 5), and saline control group (n = 4). Each mouse was surgically implanted with an osmotic minipump for methamphetamine, nicotine, cocaine, and saline based on group assignment. The minipumps were implanted in the lower back of each mouse under anesthesia. After brief recovery, the mice were returned to their home cages. The mice remained in their home cages for one week to allow for chronic infusion of the drug.

After one week, the minipumps were surgically removed under anesthesia to allow for drug washout and withdrawal to begin. Mice in the nicotine, cocaine, and saline groups were perfused 8 h after removal of the minipumps. Mice in the methamphetamine group were perfused 12 h after removal of the minipumps. These time points were chosen to represent an acute withdrawal period from each drug (e.g., a minimum of 4 h without the drug present) and based on the half-life of each drug in mice (Benuck et al., 1987; Cho et al., 2001; Norman et al., 2007; Siu and Tyndale, 2007; Shabani et al., 2012).

Tissue collection

The mice were deeply anesthetized and perfused with 15 ml of PBS followed by 50 ml of 4% formaldehyde. The brains were postfixed in formaldehyde overnight. The next day, the brains were washed for 30 min three times with PBS and transferred to a PBS/0.1% azide solution at 4°C for 2–3 d before processing via iDISCO+.

iDISCO+

The iDISCO+ procedure was performed as reported previously (Renier et al., 2014, 2016). The associated immunostaining, sample clearing, and image collection for iDISCO+ are detailed below. For an experimental design overview see Figure 1.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A, Experimental design. Mice were surgically implanted with an osmotic minipump that contained either saline or a psychostimulant (60 mg/kg/d cocaine, 4 mg/kg/d methamphetamine, or 24 mg/kg/d nicotine). They were then returned to their home cage for one week. After one week, the minipumps were surgically removed, and the mice were returned to their home cage until brain tissue was collected 8 h later (saline, cocaine, nicotine) or 12 h later (methamphetamine). Brains were then processed for whole-brain Fos immunohistochemistry and clearing via iDISCO+ and then imaged on a light-sheet microscope. Fos values were detected and registered to the Allen Brain Atlas using ClearMap Renier et al., 2016. Pearson correlations were then calculated to determine functional coactivation among brain regions. Brain regions were then grouped into modules based on their coactivation patterns through hierarchical clustering. Graph theory analyses was then performed to identify brain regions that are heavily involved in intramodular and intermodular connectivity. B, Workflow diagram of registration to the Allen Brain Atlas using ClearMap. Registration is performed by matching a the autofluorescence to a preregistered two-photon image set that has been matched to brain region delineations of the Allen Brain Atlas. The brain region demarcations mapped to the autofluorescence are then used to map onto the Fos values taken from the corresponding frame. Auto Fluo = Autofluorescence.

Immunostaining

Fixed samples were washed in 20% methanol (in double-distilled H2O) for 1 h, 40% methanol for 1 h, 60% methanol for 1 h, 80% methanol for 1 h, and 100% methanol for 1 h twice. The samples were then precleared with overnight incubation in 33% methanol and 66% dichloromethane (DCM; Sigma, catalog #270997-12X100ML). The next day, the samples were bleached with 5% H2O2 (1 volume of 30% H2O2 for 5 volumes of methanol, ice cold) at 4°C overnight. After bleaching, the samples were slowly re-equilibrated at room temperature and rehydrated in 80% methanol in double-distilled H2O for 1 h, 60% methanol for 1 h, 40% methanol for 1 h, 20% methanol for 1 h, PBS for 1 h, and PBS and 0.2% Triton X-100 for 1 h twice. The samples were then incubated in PBS, 0.2% Triton X-100, 20% dimethylsulfoxide (DMSO), 0.3 m glycine at 37°C for 2 d and then blocked in PBS, 0.2% Triton X-100, 10% DMSO, and 6% donkey serum at 37°C for 2 d. The samples were then incubated in rabbit anti c-fos (1:2000; Synaptic Systems catalog #226003) in PBS-0.2% Tween with 10 μg, ml heparin (PTwH), and 5% DMSO/3% donkey serum at 37°C for 7 d. The samples were then washed in PTwH for 24 h (five changes of the PTwH solution over that time) and incubated in donkey anti-rabbit Alexa Fluor 647 (1:500; Invitrogen, catalog #A31573) in PTwH/3% donkey serum at 37°C for 7 d. The samples were finally washed in PTwH for 1 d before clearing and imaging.

Sample clearing

Immunolabeled brains were cleared using the procedure of Renier et al. (2016). The samples were dehydrated in 20% methanol in double-distilled H2O for 1 h, 40% methanol for 1 h, 60% methanol for 1 h, 80% methanol for 1 h, 100% methanol for 1 h, and 100% methanol again overnight. The next day, the samples were incubated for 3 h in 33% methanol/66% DCM until they sank to the bottom of the incubation tube. The methanol was then washed for 20 min twice in 100% DCM. Finally, the samples were incubated in dibenzyl ether (DBE; Sigma, catalog #108014-1KG) until clear and then stored in DBE at room temperature until imaged.

Image acquisition

Left hemispheres of cleared samples were imaged in the sagittal orientation (right lateral side up). A single hemisphere was imaged as done in previous studies to avoid the need to stitch images or analyze separate image stacks for the same sample (Renier et al., 2014, 2016). Future studies examining both hemispheres would provide interesting additional results. Samples were imaged on a light-sheet microscope (Ultramicroscope II, LaVision Biotec) equipped with an sCMOS camera (Andor Neo) and 2×/0.5 objective lens (MVPLAPO 2×) equipped with a 6-mm working distance dipping cap. Imspector Microscope controller v144 software was used. The microscope was equipped with an NKT Photonics SuperK EXTREME EXW-12 white light laser with three fixed light sheet generating lenses on each side. Scans were made at 0.8× magnification (1.6× effective magnification) with a light sheet numerical aperture of 0.148. Excitation filters of 480/30, 560/40, and 630/30 nm were used. Emission filters of 525/50, 595/40, and 680/30 nm were used. The samples were scanned with a step size of 3 μm using dynamic horizontal scanning from one side (the right) for the 560- and 630-nm channels (20 acquisitions per plane with 240-ms exposure, combined into one image using the horizontal adaptive algorithm) and without horizontal scanning for the 480-nm channel using two-sided illumination (100-ms exposure for each side, combined into one image using the blending algorithm). To accelerate acquisition, both channels where acquired in two separate scans. The imaging resolution (x = 4 μm, y = 4 μm, z = 3 μm) was selected to minimize imaging time without loss in terms of sensitivity or selectivity of the cell detection process or brain segmentation. The approach of clearing, alignment, cell detection, and registration has been validated in great detail in the original Renier et al. (2016) paper and shows that cell count obtained using ClearMap is 99% similar to manual detection by a trained user (Renier et al., 2016) when using a conservative cell voxel size threshold of 20 pixel (as in our study). The cell segmentation parameters and intensity threshold used to identify Fos-positive cells in this study are the default settings included in the ClearMap package (Renier et al., 2016) without further validation, but visual confirmation was made manually on every brain to verify appropriate alignment to the reference atlas and to verify that thresholding and pixel detection were set to maximize the number of cells detected while ensuring that cells were not double counted. To account for micro-movements of the samples that may occur between scans, three-dimensional image affine registration was performed to align both channels using ClearMap (Renier et al., 2016). Representative images of Fos collected can be seen in Figure 2.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

A, Lateral to medial sagittal representative sections of the brain and zoomed in representative hippocampal subsections for each treatment. B, Comparisons of Fos values for saline versus each treatment in the dentate gyrus. See Extended Data Figure 2-2 for raw Fos values and Extended Data Figure 2-1 for comparisons of raw Fos for treatments versus saline.

Extended Data Figure 2-1

Fos counts of brain regions showing significant differences between a treatment and saline. Download Figure 2-1, TIF file.

Extended Data Figure 2-2

Table of raw Fos values and group SEMs for each treatment. Download Figure 2-2, XLS file.

Data analysis

Identification of activated brain regions

Images that were acquired from the light-sheet microscope were analyzed from the end of the olfactory bulbs (the olfactory bulbs were not included in the analysis) to the beginning of the hindbrain and cerebellum. Counts of Fos-positive nuclei from each sample were identified for each brain region using ClearMap (Renier et al., 2016). ClearMap uses autofluorescence that is acquired in the 488-nm channel to align the brain to the Allen Mouse Brain Atlas (Allen Institute for Brain Science, 2004) and then registers Fos counts to regions that are annotated by the atlas. ClearMap has been validated and used now in several recent studies to identify labeled neurons and quantify the number labeled in a given brain region (Liebmann et al., 2016; Renier et al., 2016; Kimbrough et al., 2020; Kirst et al., 2020; Qian et al., 2021). For raw Fos counts and information on brain regions showing significant differences between saline and treatment Fos levels assessed by traditional comparison see the Extended Data Figures 2-1 and 2-2. A potential confound of the present approach is that possible errors in atlas registration, although unlikely, are would impact data from smaller brain regions more than larger brain regions. The data were normalized to a log10 value to reduce variability and bring brain regions with high numbers (e.g., thousands) and low numbers (e.g., tens to hundreds) of Fos counts to a similar scale.

Identification of functional connectivity within individual networks

Separate interregional Pearson correlations were then calculated using Statistica software (Tibco) across animals in the saline, cocaine, methamphetamine, and nicotine groups to compare the log10 Fos data from each brain region to each of the other brain regions. See Table 1 for a list of brain regions, their abbreviations, and their Allen atlas grouping. It should be noted that connectivity throughout refers to functional connectivity of brain regions and not structural connectivity.

View this table:
  • View inline
  • View popup
Table 1

Brain regions list

Hierarchical clustering

Previous rat and mouse studies that examined functional connectivity used five to eight animals (Wheeler et al., 2013; Orsini et al., 2018). The number of samples that are examined in functional connectivity studies is the number of potential functional connections (i.e., 178 total brain regions all connecting with each other for each treatment). Furthermore, hierarchical clustering organizes brain regions into modules by grouping regions that show a similar functional connectivity profile across all other brain regions. Thus, more total functional connections minimize the effect that an inaccurate brain region-to-brain region functional connection has on network organization and overall network structure.

Interregional Pearson correlations were then used to calculate complete Euclidean distances between each pair of brain regions in each group of mice. The distance matrices were then hierarchically clustered using R Studio software by both row and column using the complete method to identify modules of functional connectivity within each treatment group. The hierarchical cluster dendrograms were trimmed at half the height of each given tree to split the dendrogram into specific modules. The result of a decrease in modularity that is attributable to psychostimulant use was consistent across multiple tree-cutting thresholds (Fig. 3E).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

A–D, Hierarchical clustering of complete Euclidean distance matrices for each treatment. Modules were determined by cutting each dendrogram at half of the maximal tree height. A, Relative distance of each brain region relative to the others that were examined in saline control mice. In control mice, seven distinct modules of coactivation were identified. B, Relative distance of each brain region relative to the others that were examined in cocaine mice. In cocaine mice, four distinct modules of coactivation were identified. C, Relative distance of each brain region relative to the others that were examined in methamphetamine mice. In methamphetamine mice, three distinct modules of coactivation were identified. D, Relative distance of each brain region relative to the others that were examined in nicotine mice. In nicotine mice, five distinct modules of coactivation were identified. For all distance matrices, each module is boxed in purple. For the individual brain regions that are listed in panels A–D, see Table 6. E, Number of modules in each treatment condition after cutting the hierarchical clustered dendrogram at different percentages of tree height. In all cases (except at extreme cutoff values; e.g., 90–100%), the psychostimulant networks showed lower modularity compared with the control network. See Extended Data Figure 3-1 for correlation matrices for each treatment.

Extended Data Figure 3-1

Pearson correlation matrices for showing functional connectivity measures of each treatment. Download Figure 3-1, TIF file.

Graph theory identification of functional networks

We used a graph theory-based approach to identify the functional neural networks that were associated with each treatment condition. Graph theory is a branch of mathematics that is used to analyze complex networks, such as social, financial, protein, and neural networks (Jeong et al., 2001; Barabasi, 2009; Chiang et al., 2011; Varshney et al., 2011; Babu et al., 2012; Jarrell et al., 2012; Bargmann and Marder, 2013; Wheeler et al., 2013; Oh et al., 2014; Markov et al., 2014; Cohen and D’Esposito, 2016; Vetere et al., 2017). Using graph theory, functional networks can be delineated, and key brain regions of the network can be identified (Sporns et al., 2007; Rubinov and Sporns, 2010; Wheeler et al., 2013; Vetere et al., 2017).

Previous studies of regional functional connectivity profiles using Fos have focused on global measures of connectivity (e.g., degree; Wheeler et al., 2013). However, in correlation-based networks, these measures can be strongly influenced by the size of the subnetwork (module) in which a node participates (Power et al., 2013). For the graph theory analyses, we were interested in regional properties and not module size per se. Thus, module structure needs to be considered when examining the role that each region plays in the network. To accomplish this, we used two widely used centrality metrics that were designed for application to modular systems. The Z-scored version of within-module degree (WMDz) indexes the relative importance of a region within its own module (e.g., intramodule connectivity), and the participation coefficient (PC) indexes the extent to which a region connects diversely to multiple modules (e.g., intermodule connectivity; Guimera and Nunes Amaral, 2005).

We used the Pearson correlation values that were calculated for the brain regions from each treatment. Before plotting and calculating regional connectivity metrics, the network was thresholded to remove any edges that were weaker than R = 0.75. As such, visualization and graph theory analyses were performed using only edges with positive weights. Regional connectivity metrics (PC and WMDz) were calculated as originally defined by Guimera and Nunes Amaral (2005), modified for application to networks with weighted edges. PC and WMDz were calculated using a customized version of the bctpy Python package (https://github.com/aestrivex/bctpy), which is derived from the MATLAB implementation of Brain Connectivity Toolbox (Rubinov and Sporns, 2010).

For WMDz, let ki (within-module degree) be the summed weight of all edges between region i and other regions in module si . Then, k¯si is the average within-module degree of all regions in module si , and σksi is the standard deviation of those values. The WMDz is then defined as: WMDz=ki−k¯siσksi.

This provides a measure of the extent to which each region is connected to other regions in the same module.

For PC, let kis (between-module degree) be the summed weight of all edges between region i and regions in module s, and let ki (total degree) be the summed weight of all edges between region i and all other regions in the network. The PC of each region is then defined as: Pi=1−∑s=1NM(kiski)2.

This provides a measure of the extent to which the connections of a region are distributed mostly within its own module (PC approaching 0) or distributed evenly among all modules (PC approaching 1).

A high PC was considered ≥0.30, and a high WMDz was considered ≥0.80. Previous studies have used ranges of ≥0.30–0.80 for high PC and ≥1.5–2.5 for high WMDz (Guimera and Nunes Amaral, 2005; Cohen and D’Esposito, 2016). Because of differences in the sizes/types of networks that were examined and the methods that were used (e.g., Fos vs functional magnetic resonance imaging), we adjusted the range for consideration as having high PC and WMDz accordingly.

Network visualization was performed using a combination of Gephi 0.9.2 software (Bastian et al., 2009) and Adobe Illustrator software. Nodes were positioned using the Force Atlas 2 algorithm (Jacomy et al., 2014) with a handful of nodes that were repositioned manually for better visual organization.

Results

Psychostimulant withdrawal induces restructuring of brain functional networks

We examined the ways in which withdrawal from different psychostimulants alters functional connectivity and modular structuring of the brain. For an overview of the experimental design and analysis pipeline, see Figure 1. Representative examples Fos images collected can be seen in Figure 2. For all of the drugs tested, acute withdrawal produced widespread increases in the functional connectivity of brain regions compared with saline controls (Fig. 3A–D). Importantly, modular structuring of the brain decreased in response to withdrawal from each psychostimulant compared with controls. When using a threshold of 50% of tree height, saline control mice exhibited a modular structure of the brain that contained seven modules, whereas cocaine mice had four modules, methamphetamine mice had three modules, and nicotine mice had five modules and one isolated brain region that was not grouped with any other region (i.e., interanterodorsal nucleus of the thalamus; Fig. 3A–E). Notably, the decrease in the number of modules during withdrawal was independent of the clustering thresholds that were used (Fig. 3E). These data indicate that psychostimulant withdrawal decreases modularity of the functional network compared with controls.

Characterization of individual network features

To further characterize the features of each individual network, we used a graph theory approach to identify potential hub brain regions with the most intramodular and intermodular connectivity, which may drive activity within the network and thus be critical for neuronal function in the withdrawal state. We examined positive connectivity (thresholded to a Pearson correlation coefficient >0.75 [0.75R] for inclusion as a network connection) for the network for each treatment and used the modular organization that was identified by hierarchical clustering to partition the regions of the networks. The 0.75R threshold was chosen because all of the brain regions in each network showed connections to other regions at this threshold. Previous animal model studies used various thresholds, ranging from 0.3R to 0.85R (Wheeler et al., 2013; Orsini et al., 2018), to examine connectivity. Negative network connectivity was not examined herein because the precise meaning of such connectivity is controversial and thus is not often examined in network-based approaches (Giove et al., 2009; Meunier et al., 2009; Murphy et al., 2009; Chen et al., 2011).

We determined the PC (i.e., a measure of importance for intermodular connectivity) and the WMDz (i.e., a measure of importance for intramodular connectivity; Guimera and Nunes Amaral, 2005) for all brain regions in the networks. A high PC was considered ≥0.30, and a high WMDz was considered ≥0.80. Overall, the control and nicotine networks showed much greater intermodular connectivity (high PC) and a great number of regions with both high intermodular and intramodular connectivity (high PC and WMDz). The cocaine and methamphetamine networks showed higher levels of intramodular connectivity (high WMDz) and a low number of regions with intermodular connectivity (Fig. 4A-C). We named each module in each network based on the group of brain regions with the highest WMDz score in the module and considered these regions to be drivers of activity within individual modules (Figs. 5-8 for names).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Intramodular (WMDz) and intermodular (PC) network features of each treatment. A high PC was considered ≥0.30, and a high WMDz was considered ≥0.80. A, Highlights of several regions with high PC in each module of each network (see Table 1 for names of abbreviations). B, Highlights of several regions with high WMDz (red, higher; blue, lower) in each module of each network. Note that the WMDz color intensity is only relative to the other regions within the same network and not other networks (see Table 1 for names of abbreviations). C, Total number of brain regions that accounted for high PC, high WMDz, or both in each network. The control and nicotine networks showed much greater intermodular connectivity and a greater number of regions with both high intermodular and intramodular connectivity. The cocaine and methamphetamine networks showed higher levels of intramodular connectivity and a low number of regions with intermodular connectivity.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Neural network of control mice thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1C are represented by different colored edges. See figure key for examples of each representative component of the figure.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Neural network of cocaine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1D are represented by different colored edges. See figure key for examples of each representative component of the figure.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Neural network of methamphetamine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1E are represented by different colored edges. See figure key for examples of each representative component of the figure.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Neural network of nicotine mice during withdrawal thresholded to 0.75R. Nodes/brain regions of the network are represented by circles. The size of the node represents the PC (smaller, lower PC; larger, higher PC). The internal color of each circle represents the WMDz (dark blue, lowest; dark red, highest). The color of the modules that are identified in Figure 1F are represented by different colored edges. See figure key for examples of each representative component of the figure.

The control network is driven by sensory-motor regions

The saline control network had 3176 total functional connections and consisted of seven modules, many of which were heavily driven by sensory-motor brain regions. Of these seven modules, five contained several sensory or motor brain regions that were ranked in the top five for intramodular connectivity (high WMDz). In most cases, a separate set of thalamic brain regions was responsible for intermodular connectivity (high PC; see Table 2 for a full list of values for the network). Overall, the control network had more brain regions with high WMDz, high PC, or both in individual modules compared with other networks. This indicates a more interconnected network with more hub regions (Figs. 2, 3).

View this table:
  • View inline
  • View popup
Table 2

Saline network values

The cocaine withdrawal network is driven by cortico-thalamo-hypothalamic regions

The cocaine network had 7127 total functional connections and consisted of four modules, one with the majority of all brain regions and three others with a small subset of regions. In the large module (module 1; 144 brain regions), nearly one-third (32%) of the total brain regions within the module (i.e., a mixed set of midbrain-cortico-thalamic-hypothalamic-amygdalar brain regions) had high WMDz. The brain regions that drive intramodular connectivity (high WMDz) in this module did not have any intermodular connectivity (PC). Interestingly, only three brain regions in this module (subparaventricular zone, lateral posterior nucleus of the thalamus, and frontal pole cerebral cortex) reached the criterion (PC ≥ 0.30) for a high level of intermodular connectivity, suggesting sparse communication with other modules.

One of the smaller modules, a septal (triangular nucleus of the septum) and cortical (e.g., secondary motor area and dorsal anterior cingulate area) module (module 3) had a different set of thalamic brain regions that had high PC. The other two smaller modules, a prefrontal-habenular module [module 4; dorsal peduncular area (DP), induseum griseum, and lateral habenula] and a thalamic (parafascicular nucleus, mediodorsal nucleus of the thalamus, and ventral medial nucleus of the thalamus), midbrain (nucleus of the posterior commissure), and striatal (bed nucleus of the accessory olfactory tract) module (module 2) contained regions with both a high WMDz and high PC, suggesting that these regions may be potential hubs within the network. Overall, the cocaine network contained the highest number of functional connections in any network but had minimal interconnection between modules (Figs. 2, 4; see Table 3 for a full list of values for the network).

View this table:
  • View inline
  • View popup
Table 3

Cocaine network values

The methamphetamine withdrawal network is driven by thalamic regions

The methamphetamine network had 3182 functional connections and consisted of three modules, one with the majority of all brain regions and two others with a small subset of regions. In the large module (module 1), a group of thalamic (e.g., intermediodorsal nucleus of the thalamus, paraventricular nucleus of the thalamus, intergeniculate leaflet of the lateral geniculate complex, and ventral part of the lateral geniculate complex) and amygdalar (intercalated amygdala, central amygdala, and lateral amygdala) regions had high WMDz, but these brain regions did not have any intermodular connectivity (PC), and a separate set of hypothalamic, cortical, and mid/hindbrain regions was responsible for intermodular connectivity.

The second module (module 2) had several hypothalamic (e.g., mammillary body, ventrolateral preoptic nucleus, and tuberal nucleus) and pallidal (globus pallidus and internal segment) brain regions with high WMDz and a separate set of cortical regions (e.g., DP and orbital area, ventral part) and midbrain regions (e.g., posterior pretectal nucleus, nucleus of the posterior commissure, and nucleus of Darkschewitsch) that had high interconnectivity with other modules (high PC).

The third module (module 3), a thalamic module, had several thalamic regions with high WMDz (e.g., ventral medial nucleus of the thalamus, posterior complex of the thalamus, parafascicular nucleus, and lateral dorsal nucleus of the thalamus). Interestingly, within this module, a separate set of thalamic regions (e.g., paracentral nucleus, ventral anterior-lateral complex of the thalamus, ventral posterior complex of the thalamus, and anterodorsal nucleus) had high PC, indicating that this module is internally directed by thalamic regions and also externally communicates through these regions. Overall, the methamphetamine network had a similar number of total connections to the control network, but it had minimal interconnections between modules (Figs. 2, 5; see Table 4 for a full list of values for the network).

View this table:
  • View inline
  • View popup
Table 4

Methamphetamine network values

The nicotine withdrawal network is driven by cortical and extended amygdalar regions

The nicotine network had 4957 functional connections, the second most of all conditions, and consisted of five modules and one brain region (interanterodorsal nucleus of the thalamus) that was disconnected from the entire network. Overall, the nicotine network was relatively interconnected between modules and had two large modules and three medium modules.

One of the large modules (module 1) contained midbrain (e.g., pedunculopontine nucleus and periaqueductal gray), hindbrain (e.g., pons and pontine reticular nucleus), cortical (e.g., perirhinal area, posterior auditory area, ventral anterior cingulate temporal association areas, and visceral area), and subcortical (claustrum) brain regions that had high WMDz. A separate set of cortical (e.g., postsubiculum, lateral visual area, and gustatory areas), thalamic (e.g., anteroventral nucleus of the thalamus and peripeduncular nucleus), hypothalamic (e.g., posterior periventricular nucleus, supramammillary nucleus, and periventricular zone), and midbrain (e.g., midbrain reticular nucleus, ventral tegmental area, and medial pretectal area) brain regions and a few others that included the central amygdala and vestibular nuclei had high PC.

In the second large module (module 4), a set of sensory/cortical [e.g., primary somatosensory area, lower limb, ventral agranular insular area (AIv), and primary motor area] and hypothalamic (e.g., parastriatal nucleus, retrochiasmatic area, lateral preoptic area, medial preoptic area, and zona incerta) brain regions had high WMDz. All of the same sensory/cortical and hypothalamic regions had high PC and a number of other thalamic and sensory regions. Additionally, the anterior amygdalar area (AAA) also showed both high WMDz and high PC.

One of the smaller modules (module 2) consisted of hippocampal (dentate gyrus) and sensory/cortical (e.g., posterolateral visual area, anteromedial visual area, and subiculum [SUB]) regions, along with the nucleus of reuniens (RE) with high WMDz. The SUB and RE also had high PC, along with other thalamic, hypothalamic, and midbrain regions.

In another smaller module (module 3), the precommissural nucleus (PRC), medial habenula, and intergeniculate leaflet of the lateral geniculate complex (IGL) had high WMDz and high PC. Other midbrain and thalamic regions also had high PC.

In the last small module (module 5), no regions reached the criterion for high WMDz, but the orbitofrontal cortex (lateral and ventrolateral orbital area), bed nucleus of the stria terminalis, and medial amygdalar nucleus were all in the top five values (WMDz = 0.64–0.67). However, every region in this module, with the exception of the bed nucleus of the accessory olfactory tract, reached the criterion for high PC (Figs. 2, 6; see Table 5 for a full list of values for the network).

View this table:
  • View inline
  • View popup
Table 5

Nicotine network values

View this table:
  • View inline
  • View popup
Table 6

Top to bottom order of brain regions in Figure 1

Discussion

The present study used unbiased single-cell whole-brain imaging to identify changes in brain functional architecture after withdrawal from chronic exposure to psychostimulants. Withdrawal from psychostimulants resulted in increased functional connectivity that was associated with a decrease in modularity with varying degrees of severity, depending on the drug, compared with control mice. This decreased modularity resulted in the emergence of new network architecture and organization of the brain. Using graph theory, we identified brain regions that are most responsible for intermodular and intramodular communication within each network. Withdrawal from all of the psychostimulants that were tested in the present study resulted in different network organization than the control network. The methamphetamine and cocaine withdrawal networks closely resembled each other in structural organization, primarily through thalamic motifs, whereas the nicotine withdrawal network shared some similarities with the control network. These unbiased whole-brain analyses demonstrate that psychostimulant withdrawal produces the drug-dependent remodeling of functional architecture of the brain and suggest that decreased modularity of the brain functional network may be a central feature of withdrawal.

Changes to modularity and structure of the brain caused by psychostimulant withdrawal

We found that cocaine, methamphetamine, and nicotine withdrawal produced major increases in functional connectivity throughout the brain compared with control mice. We further found that withdrawal resulted in a decrease in modular structuring of the brain compared with control mice (seven modules). The decrease in modularity was most evident for methamphetamine withdrawal (three modules) and cocaine withdrawal (four modules), whereas nicotine withdrawal showed a smaller reduction of modularity (five modules). Using the same approaches (i.e., whole-brain network analysis of Fos) reduced modularity after abstinence from alcohol dependence in mice was similarly found (Kimbrough et al., 2020). Further, humans who suffer from dementia and traumatic brain injury have shown reduced modularity that is associated with cognitive deficits (de Haan et al., 2012; Brier et al., 2014; Arnemann et al., 2015; Gallen et al., 2016; Sporns and Betzel, 2016; Bertolero et al., 2018). Changes in network structure/functional connectivity (Tomasi et al., 2010; Konova et al., 2013, 2015; Ma et al., 2015) and cognitive function (Spronk et al., 2013; Ashare et al., 2014; Sabrini et al., 2019) have been observed after chronic drug use and withdrawal, suggesting that similar mechanisms may be active between these different neural disorders.

Features of psychostimulant networks

We examined the components of individual modules within each network and found that the control network was heavily driven by sensory and motor brain regions. This result confers validity to our single-cell whole-brain network analysis approach for characterizing network features because it fits with what might be expected from a normal, awake, behaving animal that explores the environment and relies heavily on sensory/motor systems. Furthermore, the control network was more interconnected between modules overall and contained several regions that could be classified as hubs of each module that are critical for network function, based on high intramodular and intermodular connectivity. This suggests that the control brain may be more resilient to the disruption of function because additional hub regions may compensate more easily in response to such disruptions.

In the networks that were associated with withdrawal from psychostimulants, a shift was observed from sensory/motor regions to more subcortical (e.g., amygdalar, thalamic, hypothalamic, and midbrain) regions that drive the network. A similar effect was seen in nonhuman primates after cocaine abstinence (Murnane et al., 2015), and alterations of functional connectivity of the somatosensory cortex are associated with smokers (Claus and Weywadt, 2020). This may represent a shift from top-down cortical network control (Gilbert and Sigman, 2007) to bottom-up subcortical network control and may reflect the greater influence of internal drives that are associated with negative affect during withdrawal in controlling the whole-brain network (Koob, 2015). This shift may be a major reason why drugs are so addictive because higher cortical functional connectivity in humans may protect against relapse (McHugh et al., 2017).

Given the modular organization of the different networks, both the control network and nicotine network had a much higher incidence of intermodular connectivity, whereas the methamphetamine and cocaine networks had only a small subset of brain regions that were connected between different modules. Similar changes in neural activity, combined with decreases in interconnectivity and network efficiency, have been observed in humans after psychostimulant use (Ahmadlou et al., 2013; Wang et al., 2015; Liang et al., 2015). The nicotine network was different from the methamphetamine and cocaine networks and somewhat resembled a slightly altered control network. Similarities and differences in network properties of the three different drugs are likely to be caused by differences in receptor mechanisms and locations where each drug acts throughout the brain. Indeed, both cocaine and methamphetamine target the same dopamine transporter, whereas nicotine acts on nicotinic receptors (Rothman and Baumann, 2003; Nestler, 2005; Sulzer et al., 2005; D’Souza and Markou, 2011).

The interanterodorsal nucleus of the thalamus was disconnected from the nicotine network, suggesting that it may not be involved in controlling the withdrawal network, although we cannot exclude the possibility that its disconnection may instead be a critical feature of nicotine withdrawal. One of the larger modules in the nicotine network was driven by several brain regions, two of which included the AAA and AIv, which have been suggested to be associated with nicotine withdrawal in humans (Naqvi et al., 2007; Sutherland et al., 2013). The methamphetamine and cocaine networks, although having distinctly different features, shared an overall motif of lower modularity and being heavily driven by thalamic brain regions. This suggests that, in a destabilized and less structured neural network, the thalamus becomes more critical to controlling the whole-brain network. The thalamus is thought to play a major role in relaying information, and the reliance of these networks on this group of regions suggests that the thalamus is not simply a relay station but has greater importance in cognitive and emotional function (Sherman, 2007; Ahissar and Oram, 2015). Substantial evidence corroborates the importance of the thalamus in psychostimulant addiction and withdrawal. In a rat model of cocaine self-administration, the thalamus was found to be heavily involved in network function during acute abstinence, but changes in the network disappeared after two weeks (Orsini et al., 2018). Interestingly, the thalamus in humans has been shown to be hypoactive in cocaine abusers (Tomasi et al., 2007), and thalamic connectivity is predictive of cocaine dependence (Zhang et al., 2016) and altered in infants who are exposed to cocaine (Salzwedel et al., 2016). Although network changes that are induced by acute withdrawal are reversed over time (Orsini et al., 2018), prolonged use may lead to more permanent restructuring of the brain, and major differences between the nicotine and methamphetamine/cocaine networks may account for differences in the severity of each drug after long-term use (Nestler, 2005; Grant et al., 2012; Spronk et al., 2013).

In conclusion, in the past 40 years, the substance use disorder field has made tremendous progress by identifying numerous brain regions that are dysregulated after psychostimulant exposure and contribute to withdrawal behaviors (Kalivas and McFarland, 2003; Robinson and Kolb, 2004; Kalivas, 2007; Everitt et al., 2008; Jedynak et al., 2012; Koob and Volkow, 2016; Bobadilla et al., 2017). The present results confirm that a substantial number of brain regions are affected by psychostimulant exposure and suggest that a common pathway that is associated with withdrawal may not reside at the level of brain regions or even single neural circuits. Instead, these results suggest that the main common phenomenon that is observed among all three of these psychostimulants is decreased modularity of whole-brain functional architecture, suggesting that a common feature may reside at the whole-network level. This interpretation is consistent with the literature on the modularity of complex systems, including the brain and mind, showing that lower modularity reduces the capacity of the system to adapt to its environment (Kashtan and Alon, 2005). It is however worth noting that further studies will be necessary to determine whether lower modularity is simply a feature of increased functional connectivity regardless of whether it is because of withdrawal or other mechanisms. One limitation of the present study is that it did not assess withdrawal behaviors after minipump removal for comparison to network changes. This was done to avoid confounds as to the source of Fos production (e.g., withdrawal or behavioral testing). Another limitation of the present study is the lack of direct comparisons between neural activation of each treatment. The approaches used within this study can be leveraged to study and better understand numerous cognitive states (Smith and Kimbrough, 2020; Simpson et al., 2021). However, in the future assessing neural and network differences in more quantitative ways will be necessary.

In summary, the present study showed that withdrawal from psychostimulants results in changes in neural network structure, including increases in functional connectivity among brain regions and decreases in modularity. Psychostimulant withdrawal resulted in a shift from a sensory/motor-driven network to a network that is highly driven by subcortical regions. We also found that different psychostimulants do not produce the same neural networks, although methamphetamine and cocaine shared similar properties. These findings shed light on alterations of brain function that are caused by drug exposure and identify potential brain regions that warrant future study. The present study demonstrates that psychostimulant withdrawal produces drug-dependent remodeling of the functional architecture of the brain and suggests that decreased modularity of the brain functional networks may be a common feature of withdrawal. These findings may prove critical to designing future treatment approaches for withdrawal symptoms.

Footnotes

  • The authors declare no competing financial interests.

  • This work was supported by National Institutes of Health Grants DA044451, DA043799, DA047113, AA006420, AA020608, AA022977, AA027301, and AA007456; the Tobacco-Related Disease Research Program Grant 27IR-0047; Tobacco-Related Disease Research Program (grant no. T31KT1859); the 2021 Psychiatry Department Chair’s Excellence Fund to M.K.; the Pearson Center for Alcoholism and Addiction Research and the Preclinical Addiction Research Consortium at UCSD.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Ahissar E, Oram T (2015) Thalamic relay or cortico-thalamic processing? Old question, new answers. Cereb Cortex 25:845–848. doi:10.1093/cercor/bht296 pmid:24214242
    OpenUrlCrossRefPubMed
  2. ↵
    Ahmadlou M, Ahmadi K, Rezazade M, Azad-Marzabadi E (2013) Global organization of functional brain connectivity in methamphetamine abusers. Clin Neurophysiol 124:1122–1131. doi:10.1016/j.clinph.2012.12.003
    OpenUrlCrossRefPubMed
  3. ↵
    Allen Institute for Brain Science (2004) Allen mouse brain atlas. Allen Institute for Brain Science. Available at http://mouse.brain-map.org/.
  4. ↵
    Arnemann KL, Chen AJ, Novakovic-Agopian T, Gratton C, Nomura EM, D’Esposito M (2015) Functional brain network modularity predicts response to cognitive training after brain injury. Neurology 84:1568–1574. pmid:25788557
    OpenUrlCrossRefPubMed
  5. ↵
    Ashare RL, Falcone M, Lerman C (2014) Cognitive function during nicotine withdrawal: implications for nicotine dependence treatment. Neuropharmacology 76 [Pt B]:581–591. pmid:23639437
    OpenUrlCrossRefPubMed
  6. ↵
    Babu M, Vlasblom J, Pu S, Guo X, Graham C, Bean BDM, Burston HE, Vizeacoumar FJ, Snider J, Phanse S, Fong V, Tam YYC, Davey M, Hnatshak O, Bajaj N, Chandran S, Punna T, Christopolous C, Wong V, Yu A, et al. (2012) Interaction landscape of membrane-protein complexes in Saccharomyces cerevisiae. Nature 489:585–589. pmid:22940862
    OpenUrlCrossRefPubMed
  7. ↵
    Balfour DJK (2008) The psychobiology of nicotine dependence. Eur Respir Rev 17:172–181. doi:10.1183/09059180.00011001
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Barabasi AL (2009) Scale-free networks: a decade and beyond. Science 325:412–413.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Bargmann CI, Marder E (2013) From the connectome to brain function. Nat Methods 10:483–490. doi:10.1038/nmeth.2451 pmid:23866325
    OpenUrlCrossRefPubMed
  10. ↵
    Bastian M, Heymann S, Jacomy M (2009) Gephi: an open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and Social Media.
  11. ↵
    Benuck M, Lajtha A, Reith ME (1987) Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice. J Pharmacol Exp Ther 243:144–149. pmid:3668848
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Bertolero MA, Yeo BTT, Bassett DS, D’Esposito M (2018) A mechanistic model of connector hubs, modularity and cognition. Nat Hum Behav 2:765–777. doi:10.1038/s41562-018-0420-6 pmid:30631825
    OpenUrlCrossRefPubMed
  13. ↵
    Bobadilla AC, Heinsbroek JA, Gipson CD, Griffin WC, Fowler CD, Kenny PJ, Kalivas PW (2017) Corticostriatal plasticity, neuronal ensembles, and regulation of drug-seeking behavior. Prog Brain Res 235:93–112. pmid:29054293
    OpenUrlCrossRefPubMed
  14. ↵
    Brier MR, Thomas JB, Fagan AM, Hassenstab J, Holtzman DM, Benzinger TL, Morris JC, Ances BM (2014) Functional connectivity and graph theory in preclinical Alzheimer’s disease. Neurobiol Aging 35:757–768. pmid:24216223
    OpenUrlCrossRefPubMed
  15. ↵
    Chen G, Chen G, Xie C, Li SJ (2011) Negative functional connectivity and its dependence on the shortest path length of positive network in the resting-state human brain. Brain Connect 1:195–206. doi:10.1089/brain.2011.0025 pmid:22433048
    OpenUrlCrossRefPubMed
  16. ↵
    Chiang AS, Lin CY, Chuang CC, Chang HM, Hsieh CH, Yeh CW, Shih CT, Wu JJ, Wang GT, Chen YC, Wu CC, Chen GY, Ching YT, Lee PC, Lin CY, Lin HH, Wu CC, Hsu HW, Huang YA, Chen JY, et al. (2011) Three-dimensional reconstruction of brain-wide wiring networks in Drosophila at single-cell resolution. Curr Biol 21:1–11. pmid:21129968
    OpenUrlCrossRefPubMed
  17. ↵
    Cho AK, Melega WP, Kuczenski R, Segal DS (2001) Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39:161–166. doi:10.1002/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E
    OpenUrlCrossRefPubMed
  18. ↵
    Claus ED, Weywadt CR (2020) Resting-state connectivity in former, current and never smokers. Nicotine Tob Res 22:180–187.
    OpenUrl
  19. ↵
    Cohen JR, D’Esposito M (2016) The segregation and integration of distinct brain networks and their relationship to cognition. J Neurosci 36:12083–12094. pmid:27903719
    OpenUrlAbstract/FREE Full Text
  20. ↵
    de Haan W, Van Der Flier WM, Koene T, Smits LL, Scheltens P, Stam CJ (2012) Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer’s disease. Neuroimage 59:3085–3093. pmid:22154957
    OpenUrlCrossRefPubMed
  21. ↵
    D’Souza MS, Markou A (2011) Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract 6:4–16. pmid:22003417
    OpenUrlPubMed
  22. ↵
    Eisener-Dorman AF, Grabowski-Boase L, Tarantino LM (2011) Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice. Behav Brain Funct 7:29. pmid:21806802
    OpenUrlCrossRefPubMed
  23. ↵
    Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW (2008) Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363:3125–3135. pmid:18640910
    OpenUrlCrossRefPubMed
  24. ↵
    Fish EW, Riday TT, Mcguigan MM, Faccidomo S, Hodge CW, Malanga CJ (2010) Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice. Alcohol Clin Exp Res 34:81–89. pmid:19860803
    OpenUrlCrossRefPubMed
  25. ↵
    Gallen CL, Baniqued PL, Chapman SB, Aslan S, Keebler M, Didehbani N, D’Esposito M (2016) Modular brain network organization predicts response to cognitive training in older adults. PLoS One 11:e0169015. pmid:28006029
    OpenUrlCrossRefPubMed
  26. ↵
    Gilbert CD, Sigman M (2007) Brain states: top-down influences in sensory processing. Neuron 54:677–696. pmid:17553419
    OpenUrlCrossRefPubMed
  27. ↵
    Giove F, Gili T, Iacovella V, Macaluso E, Maraviglia B (2009) Images-based suppression of unwanted global signals in resting-state functional connectivity studies. Magn Reson Imaging 27:1058–1064. pmid:19695814
    OpenUrlCrossRefPubMed
  28. ↵
    Grant KM, Levan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, Carlo G, Bevins RA (2012) Methamphetamine-associated psychosis. J Neuroimmune Pharmacol 7:113–139. pmid:21728034
    OpenUrlPubMed
  29. ↵
    Guimera R, Nunes Amaral LA (2005) Functional cartography of complex metabolic networks. Nature 433:895–900. pmid:15729348
    OpenUrlCrossRefPubMed
  30. ↵
    Jacomy M, Venturini T, Heymann S, Bastian M (2014) ForceAtlas2, a continuous graph layout algorithm for handy network visualization designed for the Gephi software. PLoS One 9:e98679. pmid:24914678
    OpenUrlCrossRefPubMed
  31. ↵
    Jarrell TA, Wang Y, Bloniarz AE, Brittin CA, Xu M, Thomson JN, Albertson DG, Hall DH, Emmons SW (2012) The connectome of a decision-making neural network. Science 337:437–444. pmid:22837521
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Jedynak JP, Cameron CM, Robinson TE (2012) Repeated methamphetamine administration differentially alters fos expression in caudate-putamen patch and matrix compartments and nucleus accumbens. PLoS One 7:e34227. pmid:22514626
    OpenUrlCrossRefPubMed
  33. ↵
    Jeong H, Mason SP, Barabasi AL, Oltvai ZN (2001) Lethality and centrality in protein networks. Nature 411:41–42. pmid:11333967
    OpenUrlCrossRefPubMed
  34. ↵
    Johnson PM, Hollander JA, Kenny PJ (2008) Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav 90:409–415. pmid:18466962
    OpenUrlCrossRefPubMed
  35. ↵
    Kalivas PW (2007) Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci 9:389–397. pmid:18286799
    OpenUrlPubMed
  36. ↵
    Kalivas PW, Mcfarland K (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168:44–56. doi:10.1007/s00213-003-1393-2 pmid:12652346
    OpenUrlCrossRefPubMed
  37. ↵
    Kashtan N, Alon U (2005) Spontaneous evolution of modularity and network motifs. Proc Natl Acad Sci USA 102:13773–13778. pmid:16174729
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Kimbrough A, Lurie DJ, Collazo A, Kreifeldt M, Sidhu H, Macedo GC, D’Esposito M, Contet C, George O (2020) Brain-wide functional architecture remodeling by alcohol dependence and abstinence. Proc Natl Acad Sci USA 117:2149–2159. pmid:31937658
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Kirst C, Skriabine S, Vieites-Prado A, Topilko T, Bertin P, Gerschenfeld G, Verny F, Topilko P, Michalski N, Tessier-Lavigne M, Renier N (2020) Mapping the fine-scale organization and plasticity of the brain vasculature. Cell 180:780–795.e25. pmid:32059781
    OpenUrlCrossRefPubMed
  40. ↵
    Konova AB, Moeller SJ, Tomasi D, Volkow ND, Goldstein RZ (2013) Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. JAMA Psychiatry 70:857–868. pmid:23803700
    OpenUrlCrossRefPubMed
  41. ↵
    Konova AB, Moeller SJ, Tomasi D, Goldstein RZ (2015) Effects of chronic and acute stimulants on brain functional connectivity hubs. Brain Res 1628:147–156. pmid:25721787
    OpenUrlCrossRefPubMed
  42. ↵
    Koob GF (2015) The dark side of emotion: the addiction perspective. Eur J Pharmacol 753:73–87. pmid:25583178
    OpenUrlCrossRefPubMed
  43. ↵
    Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760–773. pmid:27475769
    OpenUrlCrossRefPubMed
  44. ↵
    Liang X, He Y, Salmeron BJ, Gu H, Stein EA, Yang Y (2015) Interactions between the salience and default-mode networks are disrupted in cocaine addiction. J Neurosci 35:8081–8090. pmid:26019326
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Liebmann T, Renier N, Bettayeb K, Greengard P, Tessier-Lavigne M, Flajolet M (2016) Three-dimensional study of Alzheimer’s disease hallmarks using the iDISCO clearing method. Cell Rep 16:1138–1152. pmid:27425620
    OpenUrlCrossRefPubMed
  46. ↵
    Ma L, Steinberg JL, Moeller FG, Johns SE, Narayana PA (2015) Effect of cocaine dependence on brain connections: clinical implications. Expert Rev Neurother 15:1307–1319. pmid:26512421
    OpenUrlPubMed
  47. ↵
    Markov NT, Ercsey-Ravasz MM, Ribeiro Gomes AR, Lamy C, Magrou L, Vezoli J, Misery P, Falchier A, Quilodran R, Gariel MA, Sallet J, Gamanut R, Huissoud C, Clavagnier S, Giroud P, Sappey-Marinier D, Barone P, Dehay C, Toroczkai Z, Knoblauch K, et al. (2014) A weighted and directed interareal connectivity matrix for macaque cerebral cortex. Cereb Cortex 24:17–36. [Database] doi:10.1093/cercor/bhs270
    OpenUrlCrossRefPubMed
  48. ↵
    Mchugh MJ, Gu H, Yang Y, Adinoff B, Stein EA (2017) Executive control network connectivity strength protects against relapse to cocaine use. Addict Biol 22:1790–1801. pmid:27600492
    OpenUrlCrossRefPubMed
  49. ↵
    Meunier D, Achard S, Morcom A, Bullmore E (2009) Age-related changes in modular organization of human brain functional networks. Neuroimage 44:715–723. pmid:19027073
    OpenUrlCrossRefPubMed
  50. ↵
    Murnane KS, Gopinath KS, Maltbie E, Daunais JB, Telesford QK, Howell LL (2015) Functional connectivity in frontal-striatal brain networks and cocaine self-administration in female rhesus monkeys. Psychopharmacology (Berl) 232:745–754. pmid:25138647
    OpenUrlPubMed
  51. ↵
    Murphy K, Birn RM, Handwerker DA, Jones TB, Bandettini PA (2009) The impact of global signal regression on resting state correlations: are anti-correlated networks introduced? Neuroimage 44:893–905. doi:10.1016/j.neuroimage.2008.09.036 pmid:18976716
    OpenUrlCrossRefPubMed
  52. ↵
    Naqvi NH, Rudrauf D, Damasio H, Bechara A (2007) Damage to the insula disrupts addiction to cigarette smoking. Science 315:531–534. pmid:17255515
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Nestler EJ (2005) The neurobiology of cocaine addiction. Sci Pract Perspect 3:4–10. pmid:18552739
    OpenUrlCrossRefPubMed
  54. ↵
    Norman AB, Tabet MR, Norman MK, Buesing WR, Pesce AJ, Ball WJ (2007) A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice. J Pharmacol Exp Ther 320:145–153. pmid:17023573
    OpenUrlAbstract/FREE Full Text
  55. ↵
    Oh SW, Harris JA, Ng L, Winslow B, Cain N, Mihalas S, Wang Q, Lau C, Kuan L, Henry AM, Mortrud MT, Ouellette B, Nguyen Tn, Sorensen SA, Slaughterbeck CR, Wakeman W, Li Y, Feng D, Ho A, Nicholas E, et al. (2014) A mesoscale connectome of the mouse brain. Nature 508:207–214. pmid:24695228
    OpenUrlCrossRefPubMed
  56. ↵
    Orsini CA, Colon-Perez LM, Heshmati SC, Setlow B, Febo M (2018) Functional connectivity of chronic cocaine use reveals progressive neuroadaptations in neocortical, striatal, and limbic networks. eNeuro 5:ENEURO.0081-18.2018.
    OpenUrl
  57. ↵
    Phillips KA, Epstein DH, Preston KL (2014) Psychostimulant addiction treatment. Neuropharmacology 87:150–160. pmid:24727297
    OpenUrlPubMed
  58. ↵
    Power JD, Schlaggar BL, Lessov-Schlaggar CN, Petersen SE (2013) Evidence for hubs in human functional brain networks. Neuron 79:798–813. pmid:23972601
    OpenUrlCrossRefPubMed
  59. ↵
    Qian K, Liu J, Cao Y, Yang J, Qiu S (2021) Intraperitoneal injection of lithium chloride induces lateralized activation of the insular cortex in adult mice. Mol Brain 14:71. pmid:33874995
    OpenUrlPubMed
  60. ↵
    Renier N, Wu Z, Simon Dj, Yang J, Ariel P, Tessier-Lavigne M (2014) iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159:896–910. doi:10.1016/j.cell.2014.10.010 pmid:25417164
    OpenUrlCrossRefPubMed
  61. ↵
    Renier N, Adams EL, Kirst C, Wu Z, Azevedo R, Kohl J, Autry AE, Kadiri L, Umadevi Venkataraju K, Zhou Y, Wang VX, Tang CY, Olsen O, Dulac C, Osten P, Tessier-Lavigne M (2016) Mapping of brain activity by automated volume analysis of immediate early genes. Cell 165:1789–1802. pmid:27238021
    OpenUrlCrossRefPubMed
  62. ↵
    Robinson Te, Kolb B (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 [Suppl 1]:33–46. pmid:15464124
    OpenUrlCrossRefPubMed
  63. ↵
    Rothman Rb, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23–40. pmid:14612135
    OpenUrlCrossRefPubMed
  64. ↵
    Rubinov M, Sporns O (2010) Complex network measures of brain connectivity: uses and interpretations. Neuroimage 52:1059–1069. pmid:19819337
    OpenUrlCrossRefPubMed
  65. ↵
    Sabrini S, Wang GY, Lin JC, Ian JK, Curley LE (2019) Methamphetamine use and cognitive function: a systematic review of neuroimaging research. Drug Alcohol Depend 194:75–87. doi:10.1016/j.drugalcdep.2018.08.041
    OpenUrlCrossRef
  66. ↵
    Salzwedel AP, Grewen KM, Goldman BD, Gao W (2016) Thalamocortical functional connectivity and behavioral disruptions in neonates with prenatal cocaine exposure. Neurotoxicol Teratol 56:16–25. pmid:27242332
    OpenUrlCrossRefPubMed
  67. ↵
    Shabani S, Mckinnon CS, Cunningham CL, Phillips TJ (2012) Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intake. Neuropharmacology 62:1134–1141. pmid:22118879
    OpenUrlPubMed
  68. ↵
    Sherman SM (2007) The thalamus is more than just a relay. Curr Opin Neurobiol 17:417–422. pmid:17707635
    OpenUrlCrossRefPubMed
  69. ↵
    Simpson S, Chen Y, Wellmeyer E, Smith LC, Montes BA, George O, Kimbrough A (2021) The hidden brain: uncovering previously overlooked brain regions by employing novel preclinical unbiased network approaches. Front Syst Neuroscil 15:595507.
    OpenUrl
  70. ↵
    Siu EC, Tyndale RF (2007) Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice. Mol Pharmacol 71:826–834. doi:10.1124/mol.106.032086
    OpenUrlAbstract/FREE Full Text
  71. ↵
    Smith LC, Kimbrough A (2020) Leveraging neural networks in preclinical alcohol research. Brain Sci 10:578. pmid:32825739
    OpenUrlPubMed
  72. ↵
    Sporns O, Betzel RF (2016) Modular brain networks. Annu Rev Psychol 67:613–640. pmid:26393868
    OpenUrlCrossRefPubMed
  73. ↵
    Sporns O, Honey CJ, Kotter R (2007) Identification and classification of hubs in brain networks. PLoS One 2:e1049. pmid:17940613
    OpenUrlCrossRefPubMed
  74. ↵
    Spronk DB, Van Wel JH, Ramaekers JQ, Verkes RJ (2013) Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev 37:1838–1859. pmid:23876288
    OpenUrlCrossRefPubMed
  75. ↵
    Stoker AK, Markou A (2011) Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice. Behav Brain Res 223:176–181. pmid:21557971
    OpenUrlCrossRefPubMed
  76. ↵
    Stoker AK, Olivier B, Markou A (2012) Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Psychopharmacology (Berl) 221:317–327. doi:10.1007/s00213-011-2578-8 pmid:22147259
    OpenUrlCrossRefPubMed
  77. ↵
    Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433. pmid:15955613
    OpenUrlCrossRefPubMed
  78. ↵
    Sutherland MT, Carroll AJ, Salmeron BJ, Ross TJ, Hong LE, Stein EA (2013) Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers. Biol Psychiatry 74:538–546. pmid:23506999
    OpenUrlCrossRefPubMed
  79. ↵
    Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, Volkow ND (2007) Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception. Psychiatry Res 155:189–201. pmid:17582746
    OpenUrlCrossRefPubMed
  80. ↵
    Tomasi D, Volkow ND, Wang R, Carrillo JH, Maloney T, Alia-Klein N, Woicik PA, Telang F, Goldstein RZ (2010) Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers. PLoS One 5:e10815. pmid:20520835
    OpenUrlCrossRefPubMed
  81. ↵
    Tracy ME, Banks ML, Shelton KL (2016) Negative allosteric modulation of GABAA receptors inhibits facilitation of brain stimulation reward by drugs of abuse in C57BL6/J mice. Psychopharmacology (Berl) 233:715–725. doi:10.1007/s00213-015-4155-z pmid:26612620
    OpenUrlCrossRefPubMed
  82. ↵
    Varshney LR, Chen BL, Paniagua E, Hall DH, Chklovskii DB (2011) Structural properties of the Caenorhabditis elegans neuronal network. PLoS Comput Biol 7:e1001066. pmid:21304930
    OpenUrlCrossRefPubMed
  83. ↵
    Vetere G, Kenney JW, Tran LM, Xia F, Steadman PE, Parkinson J, Josselyn SA, Frankland PW (2017) Chemogenetic Interrogation of a brain-wide fear memory network in mice. Neuron 94:363–374.e4. pmid:28426969
    OpenUrlCrossRefPubMed
  84. ↵
    Wang Z, Suh J, Li Z, Li Y, Franklin T, O’Brien C, Childress AR (2015) A hyper-connected but less efficient small-world network in the substance-dependent brain. Drug Alcohol Depend 152:102–108. pmid:25957794
    OpenUrlCrossRefPubMed
  85. ↵
    Wheeler AL, Teixeira CM, Wang AH, Xiong X, Kovacevic N, Lerch JP, Mcintosh AR, Parkinson J, Frankland PW (2013) Identification of a functional connectome for long-term fear memory in mice. PLoS Comput Biol 9:e1002853. pmid:23300432
    OpenUrlCrossRefPubMed
  86. ↵
    Zhang S, Hu S, Sinha R, Potenza MN, Malison RT, Li CS (2016) Cocaine dependence and thalamic functional connectivity: a multivariate pattern analysis. Neuroimage Clin 12:348–358. doi:10.1016/j.nicl.2016.08.006
    OpenUrlCrossRef
  87. ↵
    Zhu J, Zhao N, Chen Y, Zhu L, Zhong Q, Liu J, Chen T (2017) Sodium butyrate modulates a methamphetamine-induced conditioned place preference. J Neurosci Res 95:1044–1052. pmid:27426635
    OpenUrlPubMed

Synthesis

Reviewing Editor: Yavin Shaham, NIDA-IRP/NIH

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: NONE. Note: If this manuscript was transferred from JNeurosci and a decision was made to accept the manuscript without peer review, a brief statement to this effect will instead be what is listed below.

The authors satisfactory addressed many of the comments of the reviewers but one of the reviewers continue to raise significant technical concerns that should be addressed in the revision. Note that while reviewer 1 was initially very positive, after the editorial consultations the reviewer agreed that the technical concerns of reviewer 2 are valid and should be addressed in the revision. In the revision, we recommend moving most supplemental figures to the main text, and also include the new validation figures in the main text. I enclose the original reviewers’ comments below.

REVIEWER 1

The authors have addressed all my concerns by providing the requested supplementary data and by limiting the discussion to drug withdrawal. I look forward to future studies testing whether (and how) the identified network shifts affect drug-seeking.

REVIEWER 2

I apologize for the negative comments that follow, but I feel more technical questions have been raised by the inclusion of the new Extended Figure 1 than have been answered. I am uncomfortable reviewing the major biological findings of the manuscript until the technical concerns have been addressed properly. I believed this would be easy for the authors to accomplish, since such validation of their staining, imagining, and analysis must have been performed, but it is not shown in the resubmission.

Specifically, my technical concerns are not alleviated by the data shown in the resubmission. Because of the omission of raw data in the initial submission, my main critique was to include raw data in the resubmission, along with some validation of cell segmentation and brain registration. Since the graph theory analysis, which is the cornerstone of this manuscript, depends on accurate cell segmentation and brain registration, the continued omission of detailed raw data or validation is troubling.

Specifically, I asked: “ Representative IHC planes from the imaged volumes, both zoomed out for the whole plane and insets with areas of interest, of regions with significant differences between groups that are used in further analysis.”

In response, Extended Figure 1 includes low-resolution insets from a single plane within the hippocampus. These representative images raise more questions and concerns than they answer. The comparison I will draw is to papers using standard Fos IHC, where at a minimum I would ask for clear representative images from each condition. With an approach like whole brain imaging, there is an even greater need for such images and validation experiments. How consistent is staining throughout the whole volume? How consistent is imaging throughout the whole volume? How were the parameters for automated ClearMap segmentation validated?

I am surprised that such images are not being highlighted in this manuscript, like most other whole brain papers, so that readers can appreciate the scope of the data provided by this method!

These images should be easy to produce, as the full analysis is based on them. It is troubling that they are not. At the very least Extended Figure 1 should be included as a main figure so that readers of the manuscript can judge the quality of whole brain staining and imaging within the context of the more computational analysis provided. It should not be hidden in the Extended Figures.

Again, until the technical concerns are alleviated I will not comment on the interpretation of the data.

Back to top

In this issue

eneuro: 8 (6)
eNeuro
Vol. 8, Issue 6
November/December 2021
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization of the Brain Functional Architecture of Psychostimulant Withdrawal Using Single-Cell Whole-Brain Imaging
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Characterization of the Brain Functional Architecture of Psychostimulant Withdrawal Using Single-Cell Whole-Brain Imaging
Adam Kimbrough, Marsida Kallupi, Lauren C. Smith, Sierra Simpson, Andres Collazo, Olivier George
eNeuro 27 September 2021, 8 (6) ENEURO.0208-19.2021; DOI: 10.1523/ENEURO.0208-19.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Characterization of the Brain Functional Architecture of Psychostimulant Withdrawal Using Single-Cell Whole-Brain Imaging
Adam Kimbrough, Marsida Kallupi, Lauren C. Smith, Sierra Simpson, Andres Collazo, Olivier George
eNeuro 27 September 2021, 8 (6) ENEURO.0208-19.2021; DOI: 10.1523/ENEURO.0208-19.2021
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • addiction
  • functional connectivity
  • graph theory
  • iDISCO
  • Neural Activity
  • Withdrawal

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Characterization of the Tau Interactome in Human Brain Reveals Isoform-Dependent Interaction with 14-3-3 Family Proteins
  • The Mobility of Neurofilaments in Mature Myelinated Axons of Adult Mice
  • A Conserved Role for Stomatin Domain Genes in Olfactory Behavior
Show more Research Article: New Research

Neuronal Excitability

  • Glutamatergic and GABAergic receptor modulation present unique electrophysiological fingerprints in a concentration-dependent and region-specific manner
  • Persistent Firing in Hippocampal CA1 Pyramidal Cells in Young and Aged Rats
  • Allopregnanolone Effects on Inhibition in Hippocampal Parvalbumin Interneurons
Show more Neuronal Excitability

Subjects

  • Neuronal Excitability

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.